41-Oxo-45-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxa-40-azapentatetracontan-1-oic acid(CAS: 1621423-14-0)

The compound 41-Oxo-45-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxa-40-azapentatetracontan-1-oic acid (CAS: 1621423-14-0) is subject to REACH regulations in the EU, and may also be regulated by OSHA, EPA, and FDA in the U.S. Depending on its intended use, it may also need to comply with GHS classification standards.

Alternatives to 41-Oxo-45-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxa-40-azapentatetracontan-1-oic acid (CAS: 1621423-14-0) include other thienoimidazole derivatives, which may offer similar or different functional properties depending on the application. Common reagents used in synthesis include various carboxylic acids and thiophene derivatives.

Research trends for 41-Oxo-45-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxa-40-azapentatetracontan-1-oic acid (CAS: 1621423-14-0) are focusing on its potential in drug development, especially in the areas of antiviral and anticancer therapies due to its structural complexity and unique functional groups. Market trends suggest increasing interest in this compound for its biological activities.

Waste containing 41-Oxo-45-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxa-40-azapentatetracontan-1-oic acid (CAS: 1621423-14-0) should be collected and stored in appropriate containers, ensuring proper labeling. It can be disposed of through incineration or professional waste disposal services. Environmental protection measures should be taken to prevent contamination of soil and water. Consult local regulations for specific disposal procedures.